Please check the box below to prove to the site you are not a robot 🤖.
TheAnswerPage was launched in 1998 to provide daily education to healthcare providers in training and in practice.
The Answer of the Day Newsletter Sign Up
Terms & Conditions
© 2021 TheAnswerPage.com.
The COVID epidemic has accelerated research of the immune system’s integrated response to viral diseases. This 30-minute video sponsored by the American Osteopathic Association discusses cannabinoids’ impact on optimal immune function. It is presented by physician author, Jeffrey S. Block, MD – founder and principal partner of an independent professional consultancy providing client organizations with advanced scientific guidance. Dr. Block’s industry-wide expertise provides insight by translating the evolving science’s objective evidence-based data into clinical applications.
Jeffrey Sherwood Block, M.D. . is a Board-certified physician anesthesiologist and adjunct Professor at the University of Miami Miller School of Medicine. Additionally, he is a highly awarded horticulturist and certified Master Gardener educator with the University of Florida’s UF/IFAS Extension Program. Dr. Block’s textbook chapter “Endocannabinoid Receptors and Medical Cannabis” (Advanced Therapeutics in Pain Medicine – CRC Press 2020) is a sentinel work on integrated pain management. Block served as the Florida Medical Association’s “Designated Expert on Botanical Medicines” authoring mandated physician education; and in 2014 was appointed by Florida’s Surgeon General to determine the rules for Florida’s first cannabis law. His consultancy’s demonstrated insight and responsible leadership are valued by both allied professionals and new industries seeking knowledge of future uses for Cannabinoid medicines.
E.V. Berdyshev, 2000. Cannabinoid receptors and the regulation of immune response. Chemistry and Physics of Lipids 108 (2000) 169–190; www.elsevier.com/locate/chemphyslip
Biles, Mary 2019. Cannabis and the Immune System – A Complex Balancing Act. Project CBD (May 8, 2019).
Block, Jeffrey S., 2019. Endogenous Cannabinoid Receptors and Medical Cannabis. (pre-publication chapter) Advanced Therapeutics in Pain Medicine, January 2021. CRC Press.
Cabral, Guy A., Rogers, Thomas J., and Lichtman, Aron H., 2015. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. J Neuroimmune Pharmacol. 2015; 10(2): 193–203. Published online 2015 Jun 9. doi: 10.1007/s11481-015-9615-z
Centers for Disease Control and Prevention. CDC Urges Clinicians to Report Possible Cases of Unexplained Vaping-associated Pulmonary Illness to their State/Local Health Department. Clinician Outreach and Communication Activity. 2019. Published August 14, 2019.
Hernández-Cervantes R., Méndez-Díaz M., Prospéro-García Ó., and Morales-Montor J. 2017. Immunoregulatory Role of Cannabinoids during Infectious Disease. Neuroimmunomodulation 2017;24:183–199.
Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5, 400–411.
Li et al. 2019, Cell 176, 459-467.
James M. Nichols and Barbara L.F. Kaplan, 2020. Immune Responses Regulated by Cannabidiol. Cannabis and Cannabinoid Research, Vol. 5, No. 1
National Academies of Science, Engineering and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease–successes and failures. FEBS J. 2013;280(9):1918-1943.
Shmerlig, Robert H., MD, 2015. Senior Faculty Editor. First, Do No Harm. Harvard Health Publishing.
Siddappa N. Byrareddy, Mahesh Mohan, 2020. SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation? Brain, Behavior, and Immunity 87 (2020) 120–121.